REFERENCES
- Vizel M, Oster M W. Ocular side effects of cancer chemotherapy. Cancer 1982; 49: 1999–2002, [PUBMED], [INFOTRIEVE]
- Albert D M, Wong W G, Henderson E S. Ocular complications of vincristine therapy. Arch Ophthalmol. 1967; 78: 709–713, [PUBMED], [INFOTRIEVE]
- Bradley W G, Lassman L P, Pearce G W, Walton J N. The neuromyopathy of vincristine in man. Clinical, electrophysiological and pathological studies. J Neurol Sci. 1970; 10: 107–131, [PUBMED], [INFOTRIEVE], [CROSSREF]
- Weiden P L, Wright S E. Vincristine neurotoxicity. N Engl J Med. 1972; 286: 1369–1370, [PUBMED], [INFOTRIEVE]
- Wang W S, Chiou T J, Liu J H, Fan F S, Yen C C, Chen P M. Vincristine-induced dysphagia suggesting esophageal motor dysfunction: a case report. Jpn J Clin Oncol. 2000; 30(11)515–518, [PUBMED], [INFOTRIEVE], [CSA], [CROSSREF]
- Norton S W, Stockman J A, III. Unilateral optic neuropathy following vincristine chemotherapy. J Pediatr Ophthalmol Strabismus 1979; 16(3)190–193, [PUBMED], [INFOTRIEVE]
- Toker E, Yenice O, Ogut M S. Isolated abducens nerve palsy induced by vincristine therapy. J AAPOS. 2004; 8: 69–71, [PUBMED], [INFOTRIEVE], [CSA]
- Sandler S G, Tobin W, Henderson E S. Vincristine-induced neuropathy. A clinical study of fifty leukemic patients. Neurology 1969; 19(4)367–374, [PUBMED], [INFOTRIEVE]
- Favara B E, McCarthy R C, Mierau G W., Histiocytosis X. Hum Pathol. 1983; 14(8)663–676, [PUBMED], [INFOTRIEVE]